Use of the Revised Beck Depression Inventory With Intravenous Drug Users Not in Treatment


    loading  Checking for direct PDF access through Ovid

Abstract

The revised Beck Depression Inventory (BDI) was administered to 1,290 intravenous (IV) drug users who were not currently enrolled in a treatment program. A principalcomponents analysis indicated that the cognitive-affective and somatic-performance components found in psychiatric patients were also present in IV drug users, and subscales based on the compositions of these 2 components were derived. The correlations of the BDI total and 2 subscale scores with 25 of the IV drug users' background characteristics were calculated, and stepwise multiple regression analyses were used to identify the most meaningful correlates. Self-reported poor health was the most important correlate. The usefulness of the BDI for measuring self-reported depression in IV drug users who are not in treatment is discussed.

    loading  Loading Related Articles